Supernus Pharmaceuticals reported $639.24M in Current Assets for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Abbott ABT:US $ 22627M 810M
Adamas Pharmaceuticals ADMS:US 115.66M 42.45M
Aerie Pharmaceuticals AERI:US $ 289.02M 4.56M
Ani Pharmaceuticals ANIP:US $ 191.8M 9M
Antares Pharma ATRS:US $ 127.96M 5.56M
Aphria Inc APH:CN C$ 730.7M 38.56M
Aurora Cannabis Inc ACB:CN 665.89M 108.33M
Bristol Myers Squibb BMY:US $ 29161M 2050M
Canopy Growth Corp WEED:CN C$ 2.68B 163.02M
Cara Therapeutics CARA:US $ 164.47M 23.88M
Corcept Therapeutics CORT:US $ 411.27M 1.65M
Eisai 4523:JP Y 562507M 44163M
Eli Lilly And LLY:US $ 17295.5M 691M
Endo International Ordinary Shares ENDP:US $ 2569.33M 74.1M
Gw Pharmaceuticals GWPH:US $ 718.73M 10.8M
Horizon Pharma HZNP:US $ 2175.38M 344.01M
JAZZ PHA JAZZ:US $ 2953.96M 212.93M
Lannett LCI:US $ 353.56M 16.35M
Marinus Pharmaceuticals MRNS:US $ 120.92M 8.87M
Pacira Pharmaceuticals PCRX:US $ 792.58M 72.33M
Perrigo Ordinary Shares PRGO:US $ 4420.2M 68.4M
Revance Therapeutics RVNC:US $ 354.6M 51.82M
Supernus Pharmaceuticals SUPN:US $ 639.24M 53.22M
Teva Pharmaceutical Industries TEVA:US $ 12822M 421M
United Therapeutics UTHR:US $ 2317.9M 303.6M
Xeris Pharmaceuticals Inc XERS:US $ 144.59M 16.04M